Conference abstractO6 Efficacy and safety of volixibat, an IBAT Inhibitor, in patients with primary sclerosing cholangitis and moderate-to-severe pruritus: Results of the VISTAS trialPublished
O6 Efficacy and safety of volixibat, an IBAT Inhibitor, in patients with primary sclerosing cholangitis and moderate-to-severe pruritus: Results of the VISTAS trial
13 of 92 authors shown in byline order.
Regional connection
Verified An author affiliation on the Crossref record names Jefferson Einstein Philadelphia Hospital, with Jefferson Health linked by the institution reference. Affiliation source
- Institutions
- Jefferson Einstein Philadelphia Hospital, Jefferson Health
- County
- Philadelphia County
Publication record
- Type
- Conference abstract
- Venue
- O6 Efficacy and safety of volixibat, an IBAT Inhibitor, in patients with primary sclerosing cholangitis and moderate-to-severe pruritus: Results of the VISTAS trial
- Published
- Topic
- Clinical care
- Added to directory
- Source checked